Dorsey & Whitney Trust CO LLC Vertex Pharmaceuticals Inc Transaction History

Dorsey & Whitney Trust CO LLC

$1.85 Billion
Q3 2024

A detailed history of Dorsey & Whitney Trust CO LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Dorsey & Whitney Trust CO LLC holds 2,325 shares of VRTX stock, worth $1.05 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

2,325

Previous 2,285 1.75%

Holding current value

$1.05 Million

Previous $1.07 Million 0.93%

% of portfolio

0.06%

Previous 0.08%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$460.0 - $505.78 $18,400 - $20,231	40 Added 1.75%	2,325 $1.08 Million
Q2 2024 Aug 07, 2024	SELL	$392.81 - $485.53 $31,031 - $38,356	-79 Reduced 3.34%	2,285 $1.07 Million
Q1 2024 May 09, 2024	BUY	$407.69 - $446.08 $14,269 - $15,612	35 Added 1.5%	2,364 $988,000
Q4 2023 Feb 12, 2024	SELL	$343.0 - $410.68 $5,488 - $6,570	-16 Reduced 0.68%	2,329 $947,000
Q3 2023 Nov 08, 2023	BUY	$338.18 - $362.46 $4,058 - $4,349	12 Added 0.51%	2,345 $815,000
Q2 2023 Aug 10, 2023	BUY	$314.42 - $351.91 $243,361 - $272,378	774 Added 49.65%	2,333 $821,000
Q1 2023 May 11, 2023	BUY	$283.23 - $323.1 $149,262 - $170,273	527 Added 51.07%	1,559 $491,000
Q4 2022 Feb 09, 2023	SELL	$285.76 - $321.48 $34,576 - $38,899	-121 Reduced 10.49%	1,032 $298,000
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $62,159 - $69,355	227 Added 24.51%	1,153 $334,000
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $20,206 - $25,159	-86 Reduced 8.5%	926 $262,000
Q1 2022 May 11, 2022	SELL	$221.42 - $260.97 $42,734 - $50,367	-193 Reduced 16.02%	1,012 $265,000
Q4 2021 Feb 08, 2022	BUY	$177.01 - $223.45 $213,297 - $269,257	1,205 New	1,205 $264,000
Q2 2021 Aug 11, 2021	SELL	$187.49 - $221.1 $205,676 - $242,546	-1,097 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$207.02 - $241.31 $8,280 - $9,652	40 Added 3.78%	1,097 $237,000
Q4 2020 Feb 05, 2021	SELL	$207.01 - $276.09 $28,774 - $38,376	-139 Reduced 11.62%	1,057 $250,000
Q3 2020 Nov 12, 2020	BUY	$255.65 - $303.1 $11,759 - $13,942	46 Added 4.0%	1,196 $326,000
Q2 2020 Aug 13, 2020	BUY	$225.48 - $295.8 $47,576 - $62,413	211 Added 22.47%	1,150 $333,000
Q1 2020 May 12, 2020	BUY	$199.77 - $247.81 $187,584 - $232,693	939 New	939 $224,000

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dorsey & Whitney Trust CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dorsey & Whitney Trust CO LLC with notifications on news.

Account

Dorsey & Whitney Trust CO LLC Vertex Pharmaceuticals Inc Transaction History